R3 Stem Cell Clinics is initiating multiple research projects looking at the effectiveness of multiple Regenerative Medicine substances. All of these clinical studies are industry subsidized, and none are FDA clinical trials.
The studies are non-randomized, prospective and focus on clinical variables including amount of medications being taken, functional abilities, pain scales, and general health questionnaires. Because the studies are not randomized, each participant is guaranteed to receive the stem cell injection medication.
Study participants for all projects must be 18 or older, and able to participate in multiple follow up visits, either in person or possibly by email/phone correspondence. Each study is different in its protocol.
Here are the links to the various studies commencing at R3 Stem Cell Clinics:
The most revolutionary regenerative medicine treatments now being offered include amniotic and umbilical stem cell treatments. These are FDA regulated and contain growth factors, hyaluronic acid, cytokines and stem cells.